美国放射学会适宜性标准:慢性肝病
肝纤维化分期是慢性肝病发病和死亡的最重要临床决定因素,准确诊断和分期具有临床重要性。超声、CT和常规MRI可用于确立进展期纤维化/肝硬化的诊断,但对早期纤维化评估价值有限;弹性成像超声和MRI技术对肝硬化前肝纤维化评估更有用。对于进展期纤维化且有肝细胞癌风险的患者,国际指南几乎在所有情况下推荐超声作为监测手段;在超声不能很好评估肝脏的患者(包括严重脂肪变性或肥胖者),多期CT或MRI可能在肝细胞癌监测中发挥作用。
要点
- 超声、CT和常规MRI可确立进展期纤维化/肝硬化诊断,但对早期纤维化评估价值有限。
- 弹性成像超声和MRI技术对肝硬化前肝纤维化评估更有用。
- 进展期纤维化且有肝细胞癌风险者,国际指南几乎在所有情况下推荐超声监测。
核心结论
- 肝纤维化分期是慢性肝病发病和死亡的最重要临床决定因素,准确诊断和分期具有临床重要性。
- 超声、CT和常规MRI可确立进展期纤维化/肝硬化诊断,但对早期纤维化评估价值有限。
- 弹性成像超声和MRI技术对肝硬化前肝纤维化评估更有用。
- 进展期纤维化且有肝细胞癌风险者,国际指南几乎在所有情况下推荐超声作为监测手段。
- 超声不能很好评估肝脏者(包括严重脂肪变性或肥胖),多期CT或MRI可能在肝细胞癌监测中发挥作用。
研究设计与样本
- 美国放射学会适宜性标准为基于证据的指南,由多学科专家小组每年审查。
- 指南制定和修订包括对同行评审期刊当前医学文献的广泛分析。
- 采用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像和治疗程序适宜性进行评级。
- 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
临床应用与阅片要点
- 超声、CT和常规MRI可用于确立进展期纤维化/肝硬化诊断,但对早期纤维化评估价值有限。
- 弹性成像超声和MRI技术对肝硬化前肝纤维化评估更有用。
- 进展期纤维化且有肝细胞癌风险者,国际指南几乎在所有情况下推荐超声作为监测手段。
- 超声不能很好评估肝脏者(包括严重脂肪变性或肥胖),多期CT或MRI可能在肝细胞癌监测中发挥作用。
- 有肝细胞癌病史者,多期CT和MRI均可用于继续监测,超声造影在该场景中可能具有新兴作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and staging of liver fibrosis are clinically important. Ultrasound, CT, and conventional MRI can be used to establish the diagnosis of advanced fibrosis/cirrhosis but have limited utility for assessing earlier stages of fibrosis. Elastography-based ultrasound and MRI techniques are more useful for assessment of precirrhotic hepatic fibrosis. In patients with advanced fibrosis at risk for hepatocellular carcinoma (HCC), ultrasound is the surveillance modality recommended by international guidelines in nearly all circumstances. However, in patients in whom ultrasound does not assess the liver well, including those with severe steatosis or obesity, multiphase CT or MRI may have a role in surveillance for HCC. Both multiphase CT and MRI can be used for continued surveillance in patients with a history of HCC, and contrast-enhanced ultrasound may have an emerging role in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Bashir MR, Horowitz JM, Kamel IR, et al. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol. 2020. PMID: 32370979. doi:10.1016/j.jacr.2020.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。